(Q46459487)

22 December 2017

title

New Agents for Acute Treatment of Migraine: CGRP Receptor Antagonists, iNOS Inhibitors (English)

1 reference

22 December 2017

1 reference

2

Peter J Goadsby

1 reference

22 December 2017

Jan Hoffmann

1

1 reference

22 December 2017

publication date

1 February 2012

1 reference

22 December 2017

Current treatment options in neurology

published in

1 reference

22 December 2017

volume

14

1 reference

22 December 2017

issue

1

1 reference

22 December 2017

page(s)

50-59

1 reference

22 December 2017

https://scigraph.springernature.com/pub.10.1007/s11940-011-0155-4

exact match

0 references

cites work

The global burden of headache: a documentation of headache prevalence and disability worldwide

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0155-4

The global burden of disease study: implications for neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0155-4

Epidemiology of headache in a general population--a prevalence study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0155-4

Headache epidemiology. Emphasis on migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0155-4

Prevalence of frequent headache in a population sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0155-4

Migraine in the United States: epidemiology and patterns of health care use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0155-4

The epidemiology of primary headache disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0155-4

Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0155-4

CGRP and its receptors provide new insights into migraine pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0155-4

Lysine-acetylsalicylic acid in acute migraine attacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0155-4

Intravenous aspirin (lysine acetylsalicylate) in the inpatient management of headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0155-4

BI 44370 TA, an oral CGRP antagonist for the treatment of acute migraine attacks: results from a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0155-4

Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0155-4

Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0155-4

Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0155-4

Preclinical pharmacological profile of the selective 5-HT1F receptor agonist lasmiditan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0155-4

5-Hydroxyptryptamine 1F (5-HT1F) receptor agonism. A possible new treatment principle for acute migraine attacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0155-4

Acute treatment of migraine with the selective 5-HT1F receptor agonist lasmiditan--a randomised proof-of-concept trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0155-4

Changes in cerebral blood flow velocity after treatment with sumatriptan or placebo and implications for the pathophysiology of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0155-4

Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0155-4

Differential distribution of calcitonin gene-related peptide and its receptor components in the human trigeminal ganglion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0155-4

Calcitonin gene-related peptide in the brain, spinal cord, and some peripheral systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0155-4

Neuroanatomical localization, pharmacological characterization and functions of CGRP, related peptides and their receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0155-4

CGRP release and c-fos expression within trigeminal nucleus caudalis of the rat following glyceryltrinitrate infusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0155-4

Calcitonin gene-related peptide (CGRP) modulates nociceptive trigeminovascular transmission in the cat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0155-4

Recent advances in understanding migraine mechanisms, molecules and therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0155-4

The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0155-4

Vasoactive peptide release in the extracerebral circulation of humans during migraine headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0155-4

CGRP may play a causative role in migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0155-4

Nitric oxide is a key molecule in migraine and other vascular headaches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0155-4

A cDNA encoding the calcitonin gene-related peptide type 1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0155-4

RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0155-4

Localization and modulation of calcitonin gene-related peptide-receptor component protein-immunoreactive cells in the rat central and peripheral nervous systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0155-4

Possible sites of action of the new calcitonin gene-related peptide receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0155-4

Immunohistochemical localization of calcitonin receptor-like receptor and receptor activity-modifying proteins in the human cerebral vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0155-4

Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0155-4

Randomized, controlled trial of telcagepant for the acute treatment of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0155-4

CGRP receptor antagonism and migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0155-4

Randomized, controlled trial of telcagepant over four migraine attacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0155-4

Antimigraine efficacy of telcagepant based on patient's historical triptan response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0155-4

Single- and multiple-dose pharmacokinetics and tolerability of telcagepant, an oral calcitonin gene-related peptide receptor antagonist, in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0155-4

Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the acute treatment of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0155-4

Characterization of the calcitonin gene-related peptide receptor antagonist telcagepant (MK-0974) in human isolated coronary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0155-4

Nitric oxide synthase inhibition lowers activity of neurons with meningeal input in the rat spinal trigeminal nucleus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0155-4

Systemic nitroglycerin induces Fos immunoreactivity in brainstem and forebrain structures of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0155-4

Nitrergic and glutamatergic neuronal mechanisms at the trigeminovascular first-order synapse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0155-4

Nitric oxide potentiates response of trigeminal neurones to dural or facial stimulation in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0155-4

Fos expression in the trigeminocervical complex of the cat after stimulation of the superior sagittal sinus is reduced by L-NAME.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0155-4

Nitric oxide synthase inhibitors can antagonize neurogenic and calcitonin gene-related peptide induced dilation of dural meningeal vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0155-4

Glyceryl trinitrate induces attacks of migraine without aura in sufferers of migraine with aura

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0155-4

Biphasic response to nitric oxide of spinal trigeminal neurons with meningeal input in rat--possible implications for the pathophysiology of headaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0155-4

Glyceryl trinitrate triggers premonitory symptoms in migraineurs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0155-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0155-4

GW274150 and GW273629 are potent and highly selective inhibitors of inducible nitric oxide synthase in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0155-4

GW274150, a novel and highly selective inhibitor of the inducible isoform of nitric oxide synthase (iNOS), shows analgesic effects in rat models of inflammatory and neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0155-4

Lack of efficacy of the selective iNOS inhibitor GW274150 in prophylaxis of migraine headache.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0155-4

Long-Term Tolerability of Telcagepant for Acute Treatment of Migraine in a Randomized Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0155-4

Nitric oxide synthase inhibition in migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11940-011-0155-4

Messenger molecules and receptor mRNA in the human trigeminal ganglion

21 January 2018

1 reference

12 December 2020

Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system

1 reference

12 December 2020

The vascular theory of migraine--a great story wrecked by the facts

1 reference

12 December 2020

An in vivo rat model to study calcitonin gene related peptide release following activation of the trigeminal vascular system

1 reference

12 December 2020

Innervation of the human middle meningeal artery: immunohistochemistry, ultrastructure, and role of endothelium for vasomotility

1 reference

12 December 2020

Efficacy and safety of intravenous acetylsalicylic acid lysinate compared to subcutaneous sumatriptan and parenteral placebo in the acute treatment of migraine. A double-blind, double-dummy, randomized, multicenter, parallel group study. The ASASUMA

1 reference

12 December 2020

Calcitonin gene-related peptide and its receptors: molecular genetics, physiology, pathophysiology, and therapeutic potentials

1 reference

12 December 2020

10.1007/S11940-011-0155-4

Identifiers

DOI

1 reference

22 December 2017

PubMed ID

22090312

1 reference

22 December 2017